Takeda Pharmaceutical Company Limited

4502.T·Tokyo·Healthcare
Compare
6,888.00+300.00 (+4.55%)today
At close: Nov 5, 3:30 PM JST · May be delayed up to 20 min · JPY

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6,588.00
Open6,841.00
Day range6,833.006,989.00
52-week range4,141.006,989.00
Off day high−1.45%
Off 52-week high−1.45%
Volume6.57M
Avg. volume (3M)4.32M
Market cap11.00T
EPS (TTM)22.32
Forward P/E49.06
P/E ratio (TTM)308.60
Dividend yield3.10% (204.00)
Beta (5Y)0.08
Shares outstanding1.60B
Short interest—
Earnings dateJan 28, 2027
Analyst target6,815.81
Profit margin0.87%

Against its peers

Compare in full ›
4502.T 0QFP.IL SUNPHARMA.NS AUROPHARMA.BO IPCALAB.BO EMCURE.NS
Market cap 11.00T 4.46T 4.39T 1.04T 494.67B 425.90B
P/E (TTM) 308.6 18.8 40.0 30.4 37.8 39.0
Forward P/E 49.1 — 29.0 23.9 27.7 27.9
Price/book 1.5 2.1 4.9 3.0 6.1 8.0
Dividend yield 3.10% 7.74% 0.90% 0.33% 0.30% 0.17%
1-year change +58.29% 0.00% +5.19% +1.70% +51.51% +49.21%
Today +4.55% +156.25% +3.14% +5.13% −1.18% +3.92%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Latest news

All 4502.T news ›
MarketScreener·Positive

Takeda Pharmaceutical Raises Annual Guidance

Published on 10/29/2026 at 03:28 am EDT - Modified on 10/29/2026 at 03:29 am EDT Takeda Pharmaceutical raised its annual earnings forecasts, after swinging to a net profit in the second quarter. The Japanese drugmaker on Thursday reported…

From the 4Search news index, newest first.

In the news

19mentions in 30 days
19with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance